baber/WOPTO huggingface dataset:
Patent JP-3398785-B2 (JP)
IPC: F16D43/22
Filed: 1992-10-06
Granted: 2003-04-21
Abstract: The automatic clutch controller receives inputs from an engine speed sensor (13) and a transmission input speed sensor (31) to develop a clutch actuation signal to control a clutch actuator (27) between disengaged and fully engaged positions. Throttle setting is used to distinguish between a launch mode corresp. to normal vehicle start and a creep mode when a reference speed is determined from throttle setting and engine speed. An integral error function and a differential engine speed function are combined to adjust clutch engagement to vehicle loading. The controller includes a prefilter (68) and a compensator (70) to reduce the need to cater for individual vehicles or vehicle models.
Patent JP-H07116133-B2 (JP)
IPC: C07C403/08
Filed: 1988-11-29
Abstract: Process for preparing vitamin A which is practically free from 2- cis and 6-cis isomers by hydrogenation of vitamin A aldehyde, optionally in the form of a complex with hydroquinone, in the presence of a ruthenium hydride as catalyst.
Patent JP-2897406-B2 (JP)
IPC: H01L21/60
Filed: 1990-11-06
Granted: 1999-05-31
Abstract: PURPOSE:To completely reproduce a semiconductor device without destroying any semiconductor element and insulating substrate by removing the semiconductor element from the insulating substrate while a semiconductor element mounting section is heated and a shear force is applied to the element and substrate in a plane perpendicular to an active element forming surface. CONSTITUTION:A hot blast is supplied to a semiconductor element 2 and substrate from a hot blast supplying port 12. As a result, an insulating resin 5 is heated and softens. When a shear force generating jig 11 is pressed against the side face of the element 2 and a force is applied in the direction shown by the arrow under such condition, the element 2 can be removed from the substrate. Then, after removing the resin 5 left on the substrate 1 with a solvent, etc., the resin 5 is newly placed on the substrate 1 and the removed semiconductor element 2 is positioned on the resin 5. After positioning the element 2, the resin 5 is hardened.
Patent JP-H071526-B2 (JP)
IPC: G11B5/33
Filed: 1989-11-30
Abstract: A recording head includes at least one magnetic pole and magnetic side shields adjacent to the pole, the side shields disposed to shield the pole from adjacent tracks on a magnetic medium. Embodiments are disclosed for both longitudinal and vertical recording in monopole, two pole, and three-pole heads, including inductive, MR and Hall-type read elements.
Patent JP-3343220-B2 (JP)
IPC: B21D28/20
Filed: 1998-11-26
Granted: 2002-11-11
Abstract: The press has a frame (2) in which is located a drive shaft (1) on which at least one connecting rod unit (8) is eccentrically located. The connecting rod unit is connected to a pressure column via a rocker member (27,28) to which a one-armed lever (33,34) is articulatedly connected. The rocker member is point-symmetrically formed and is located in the press frame at its symmetry point.
Patent JP-H0121966-B2 (JP)
IPC: A47C7/50
Filed: 1984-04-27
Abstract: PCT No. PCT/NO84/00022 Sec. 371 Date Dec. 21, 1984 Sec. 102(e) Date Dec. 21, 1984 PCT Filed Apr. 27, 1984 PCT Pub. No. WO84/04235 PCT Pub. Date Nov. 8, 1984.A supporting device for a person, said device having a posterior supporting face (2) and thigh supporting members (5,6) designed to engage a front portion of the person's respective thighs. A leg (3) depends from the posterior supporting face (2) and is suitably, through a transition member (12), connected to a leg base (13) being provided with casters (14). An anti-tilting device (15) may be provided at the rear end of the base (13). Foot engaging projection (16) may be present to contact a floor upon downward pressure thereon. The supporting device provides a stable 3-points support for a person assuming a standing-like sitting position.
Patent JP-2520107-B2 (JP)
IPC: G01N33/577
Filed: 1985-06-21
Granted: 1996-07-31
Abstract: PCT No. PCT/AU85/00136 Sec. 371 Date Apr. 24, 1986 Sec. 102(e) Date Apr. 24, 1986 PCT Filed Jun. 21, 1985 PCT Pub. No. WO86/00414 PCT Pub. Date Jan. 16, 1986.An in vitro diagnostic method for detecting the presence in a patient of cancer cells or other cells producing mucin antigens comprises the step of testing a sample of a physiological fluid, particularly a sample of blood, blood serum or blood plasma, taken from the patient to detect the presence of small intestine mucin antigen (SIMA) and/or large intestine mucin antigen (LIMA) in the sample. An in vitro diagnostic kit is also disclosed.
Patent JP-H0618604-B2 (JP)
IPC: B01D53/50
Filed: 1985-09-06
Abstract: To separate liquid droplets from the gas flow inside a vertical pipe (1), especially in a gas washing plant in combustion gas desulphurating installations, separating slats (6) are arranged in groups and are fixed obliquely and at a certain distance in a parallel manner in relation to one another on a frame between two carrier plates (8, 9) in the gas flow pipe (1), whereby the assemblies (5) are arranged in several parallel rows and provided with rinsing tubes (7). To improve the separation performance also during the rinsing process, a slightly-inclined collection tray (11) is provided next to each of the lower ends of the separation slats (6) which have a wavy design, into which the droplets entrained during the rinsing process are conveyed.
Patent JP-3567990-B2 (JP)
IPC: A61Q19/04
Filed: 1993-07-12
Granted: 2004-09-22
Abstract: The present invention relates to pharmaceutical compositions for topical application comprising a safe and effective amount of a pharmaceutical active, from about 0.1% to about 10.0% of a high molecular weight cationic polymer, from about 0.05% to about 5% of a high HLB non-ionic surfactant, and from about 0.1% to about 25% of an alkoxylated ether. In further embodiments, these compositions also comprise from about 0.01% to about 5% of a low HLB non-ionic surfactant.
Patent JP-3635091-B2 (JP)
IPC: A01N25/28
Filed: 1995-07-13
Granted: 2005-03-30
Abstract: A method of controlling the particle size and particle size distribution of an aqueous emulsion having a non-aqueous disperse phase during the production thereof, in which the production of the emulsion is carried out in the presence of a dispersion of a templating agent, such as a polymer latex, and surfactant Particle size and particle size distribution of the dispersion is controlled by selecting the templating agent and surfactant such as to cause deposition of the disperse phase on particles of the dispersed templating agent, such that the particle size distribution of the templating agent provides a template for the particle size distribution of the final emulsion.
Patent JP-H0775539-B2 (JP)
IPC: G01N33/569
Filed: 1991-02-11
Abstract: A method provided for assaying for human immunodeficiency virus comprises: seeding dishes with cells susceptible to HIV infection; adding to the dishes a sample to be tested for HIV infection; incubating the cells; exposing the cells to a first antibody reactive with HIV proteins; exposing the cells to marker-conjugated antibody reactive with the first antibody; examining the dishes with a suitable microscope; and counting the number of foci of marker-positive cells per dish to determine the number of infected cells in the dish. The process can be used to detect and to quantify HIV-infected cells, which permits monitoring of the effects of drug therapy on the levels of HIV expression in AIDS patients, as well as providing a quantitative measure of HIV expression in asymptomatic HIV antibody-positive individuals.
Patent JP-H075527-B2 (JP)
IPC: A61K47/48
Filed: 1991-03-22
Abstract: The subject matter of the present invention relates to bifunctional cyclohexyl DPTA ligands and methods for utilizing these compounds.
Patent JP-3922309-B2 (JP)
IPC: F16L37/084
Filed: 1997-07-24
Granted: 2007-05-30
Abstract: This invention provides a connector for coupling a male and a female component, the connector including a member for locating the female component with respect to the male component and a locking member for coupling the female component to the male component. The locking member rotates with respect to the locating member in order to provide for the coupling and uncoupling of the components.
Patent JP-3610068-B2 (JP)
IPC: B65D8/02
Filed: 1995-09-12
Granted: 2005-01-12
Abstract: The lid (12) is held on the barrel by a clamping ring (14) one web of which fits over the top of the lid. The other web lies against the sloping lower face of a flange around the barrel opening and extends into a neck section of the barrel of reduced diameter. The neck section increases conically to the full diameter of the barrel. A seal (30) is mounted between lid and barrel rim. The shape of the cover is in the form of a truncated cone with an indent in the conical section in which a filler opening (42) is formed.
Patent JP-3032294-B2 (JP)
IPC: A61P9/06
Filed: 1991-05-15
Granted: 2000-04-10
Abstract: The present invention is direct to a new class of 1-piperidinyl alkanoylarylsulfonamides and their use as antiarrhythmic agents.
Patent JP-H07110850-B2 (JP)
Inventor: LOWE JOHN ADAMS III
IPC: C07D215/42
Filed: 1992-05-05
Abstract: PCT No. PCT/US92/03571 Sec. 371 Date Dec. 14, 1993 Sec. 102(e) Date Dec. 14, 1993 PCT Filed May 5, 1992 PCT Pub. No. WO92/06079 PCT Pub. Date Apr. 16, 1992The present invention relates to novel fluoroalkoxybenzylamino derivatives of nitrogen containing heterocyclic compounds, and specifically, to compounds of the formula    <IMAGE>  I  wherein Q, X1, x2 and X3 are as defined below. These novel compounds are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders.
Patent JP-4099829-B2 (JP)
IPC: C07K19/00
Filed: 1995-10-27
Granted: 2008-06-11
Abstract: A glucocorticoid-induced protein, TIGR, that is produced by cells of the trabecular meshwork can be used to diagnose glaucoma. The TIGR protein, anti-TIGR antibodies, and TIGR encoding sequences also provide a diagnostic for glaucoma and its related diseases.
Patent JP-2952040-B2 (JP)
IPC: C07C41/14
Filed: 1991-09-09
Granted: 1999-09-20
Abstract: PCT No. PCT/SE91/00589 Sec. 371 Date Mar. 24, 1993 Sec. 102(e) Date Mar. 24, 1993 PCT Filed Sep. 9, 1991 PCT Pub. No. WO91/10633 PCT Pub. Date Jul. 25, 1991.Process for the production of di-trimethylolpropane (di-TMP), which comprises subjecting a solution containing less than 3 per cent by weight, preferably less than 1 per cent by weight of water, free trimethylolpropane (TMP) and/or partial ester between TMP and a monocarboxylic acid or its anhydride having 1-4 carbon atoms in the chain, which partial ester on average contains 1.0-2.5, preferably 1.0-2.0 ester groups per molecule to an etherification reaction by heating to 50 DEG -200 DEG  C., preferably 70 DEG -190 DEG  C. in the presence of an acid catalyst in solid state or in dissolved state until at most 30%, preferably at most 15% of the total content of free TMP and partial ester of TMP in the solution has been etherified to free di-TMP and partial ester of di-TMP respectively, at the same time continuously removing etherification water formed at the etherification reaction under vacuum at a pressure of 0.1-200 mm Hg, preferably 0.1-50 mm Hg or by an azeotropic distillation by means of a compound such as hexane, toluene, xylene or the like forming an azeotropic mixture, and recovering free di-TMP and di-TMP bonded as a partial ester respectively from the reaction mixture in a suitable way.
Patent JP-3537436-B2 (JP)
IPC: A61B17/17
Filed: 1994-01-24
Granted: 2004-06-14
Abstract: An anterior spine fixation system comprises an elongated fixation plate (70) having a pair of screw bores (74) at opposite ends thereof defined between a lower surface (72) adapted to engage the anterior portion of the vertebrae and an opposite upper surface (71); several bone engaging screws (77), one each for each of said pair of screw bores; a fixation bore (75) defined in said plate between said screw bores, and a locking screw having a shank adapted to be received within said fixation bore and an enlarged head adapted to simultaneously cover a portion of the head of both screws received within said pair of screw bores, said head of said locking screw configured to reside within said fixation bore recess without extending above said upper surface of said plate. <IMAGE>
Patent JP-4009320-B2 (JP)
IPC: A61P21/00
Filed: 1996-12-20
Granted: 2007-11-14
Abstract: The present invention relates to novel classes of compounds which are inhibitors of interleukin-1  beta  converting enzyme. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting ICE activity and consequently, may be advantageously used as agents against interleukin-1 and apoptosis-mediated diseases, including inflammatory diseases, autoimmune diseases, proliferative, infectious, and degenerative diseases. This invention also relates to methods for inhibiting ICE activity and methods for treating interleukin-1 mediated diseases using the compounds and compositions of this invention.
Patent JP-4536828-B2 (JP)
IPC: C09K23/00
Filed: 1997-01-22
Granted: 2010-09-01
Abstract: PCT No. PCT/NL97/00021 Sec. 371 Date Sep. 23, 1997 Sec. 102(e) Date Sep. 23, 1997 PCT Filed Jan. 22, 1997 PCT Pub. No. WO97/26984 PCT Pub. Date Jul. 31, 1997The invention relates to a dispersing agent or salts thereof, comprising the reaction product of: A one or more polyisocyanates with an average functionality of about 2 to about 5, with B a compound of the type Y-R-X, wherein Y represents a ring structure with at least one nitrogen atom in the ring, R represents a chain of at least three atoms and X has the meaning O-R1 or N(R1) (R2), wherein R1 is H or a group of the formula R3-Z, wherein R3 represents a chain with at least two atoms and Z represents OH or NH2, and R2 represents a group of the formula R3-Z, which compound is obtainable through reaction of an acrylate compound or an epoxide compound with a cyclic compound which has at least one group of the structure   <IMAGE>    in the ring.
Patent JP-3162406-B2 (JP)
IPC: G06K17/00
Filed: 1997-01-22
Granted: 2001-04-25
Abstract: A device for processing and storing data, in particular a chip card, includes a first interface with contacts and a second contactless interface for receiving energy or power from and for communication with a terminal device. A first controllable switching device connects either the first or the second interface to a non-volatile semiconductor memory through address, data and control lines. A logic circuit drives the first controllable switching device. A second controllable switching device disposed between the first controllable switching device and the memory can be driven at least by the logic circuit and an address signal present on the address lines.
Patent JP-4125790-B2 (JP)
IPC: A61K31/519
Filed: 1997-12-12
Granted: 2008-07-30
Abstract: The invention relates to triazolo[4,5-d]pyrimidin-3-yl derivatives which are useful in the treatment of platelet aggregation disorders.
Patent JP-4307552-B2 (JP)
IPC: C12N5/08
Filed: 1997-03-14
Granted: 2009-08-05
Abstract: Polynucleotides encoding mammalian ECM signalling molecules affecting the cell adhesion, migration, and proliferation activities characterizing such complex biological processes as angiogenesis, chondrogenesis, and oncogenesis, are provided. The polynucleotide compositions include DNAs and RNAs comprising part, or all, of an ECM signalling molecule coding sequence, or biological equivalents. Polypeptide compositions are also provided. The polypeptide compositions comprise mammalian ECM signalling molecules, peptide fragments, inhibitory peptides capable of interacting with receptors for ECM signalling molecules, and antibody products recognizing Cyr61. Also provided are methods for producing mammalian ECM signalling molecules. Further provided are methods for using mammalian ECM signalling molecules to screen for, and/or modulate, disorders associated with angiogenesis, chondrogenesis, and oncogenesis: ex vivo methods for using mammalian ECM signalling molecules to prepare blood products are also provided.
Patent JP-3367105-B2 (JP)
IPC: A61K31/407
Filed: 1999-03-04
Granted: 2003-01-14
Abstract: Macrolide compounds, such as the FK506 Substance and its related compounds are provided for the prevention or treatment of adult respiratory distress syndrome. Composition containing such compounds is also disclosed.
Patent JP-4245193-B2 (JP)
IPC: H02N2/10
Filed: 1998-05-11
Granted: 2009-03-25
Abstract: A high power ultrasonic motor (21). The motor includes a housing (23) having a predetermined geometry and a transducer (41). The transducer has an active element (42) made from a magnetostrictive material and a coil (51) for producing an electromagnetic filed which extends through at least a portion of the active element. The active element is changeable between a first shape when in the absence of the electromagnetic field and a second shape when in the presence of the electromagnetic field. An electrical signal is provided to the coil for producing the electromagnetic field. An acoustic element (96) is connected to the transducer for providing ultrasonic energy to perform work.
Patent PL-75312-B2 (PL)
Title: 17alpha-ehtynylestriols[au3982772a]
IPC: A61K31/565
Filed: 1972-03-22
Abstract: 1336703 17α-Ethynylestriols ELI LILLY & CO 23 March 1972 [24 March 1971 (2) 15 April 1971 23 April 1971] 13523/72 Heading C2U The invention comprises (a) the 3-cyclopentyl ether of 17α-ethynylestriol (I); and (b) a process for separating a compound of formula (wherein R<SP>11</SP> is H, C 1-3 alkyl or C 5-6 cycloalkyl) from a mixture thereof with its 17α-hydroxy- 17#-ethynyl isomer, by treating the mixture with acidic acetone to convert the latter component to its 16,17-acetonide which is then removed, e.g. by chromatography or crystallization. The starting mixture may be obtained by ethynylation of a 16α-alkanoyloxy-estrone or a 3-alkyl ether, 3-cycloalkyl ether or 3-alkanoate thereof. When R<SP>11</SP> is H in the separated compound II, it may be etherified in the 3-position by reaction with an alkali metal alkoxide or thallous ethoxide and reaction of the resulting salt with a C 5-6 cycloalkyl halide. Compound I is said to be estrogenic, and may be made up with carriers into pharmaceutical compositions for oral and parenteral administration. Reference has been directed by the Comptroller to Specification 1,110,759.
[GB1336703A]
Patent ES-2224885-B2 (ES)
Title: Procedimiento para la produccion de ciclohexanol y ciclohexanona.
Inventor: OCZKOWICZ STANISLAW
IPC: C07C39/00
Filed: 2004-01-16
Granted: 2006-04-16
Abstract: Procedimiento para la producción de ciclohexanol y ciclohexanona. El ciclohexanol y la ciclohexanona se preparan mediante oxidación del ciclohexano a una mezcla de reacción (oxidato) que contiene principalmente hidroperóxido de ciclohexilo y ciclohexanol, ciclohexanona y otros productos de oxidación, procedimiento que es seguido de una descomposición selectiva de dicho hidroperóxido de ciclohexilo preparado en el reactor o reactores de descomposición separado, en fase líquida, a una temperatura de 70 a 100°C, en presencia de un catalizador que es la disolución de un metal de una sal de valencia variable y la mayoría de los productos de reacción que inhiben la reacción de descomposición y la desactivación del catalizador, incluyendo, en primer lugar, el agua, se extraen de manera continua del reactor/reactores. El oxidato antes de alimentar el reactor/reactores de descomposición se expande a la presión de la reacción de descomposición, se lava con agua, se extrae el agua arrastrada y disuelta en la capa orgánica. El producto que abandona el reactor/reactores de descomposición se lava con agua, antes de dirigirlo a una unidad de recuperación del ciclohexano no convertido.
Patent ES-2607252-B2 (ES)
Title: Dispositivo de metacrilato con escala milimetrada para medir la movilidad del primer y quinto radios del pie en carga y descarga
Inventor: MUNUERA MARTINEZ PEDRO VICENTE
IPC: A61B5/11
Filed: 2015-09-29
Granted: 2017-11-30
Abstract: Dispositivo de metacrilato con escala milimetrada para medir la movilidad del primer y quinto radios del pie en carga y descarga que tiene por objeto cuantificar el movimiento de dorsiflexión y plantarflexión del primer y quinto radios del pie, aportando a los clínicos una herramienta de fácil manejo, pequeña y ligera, que complementaría a la habitual maniobra de exploración de este movimiento, totalmente subjetiva. Su uso principal será el diagnóstico de alteraciones funcionales del primer y quinto radios, como lo son el primer (o quinto) radio dorsalflexionado y plantarflexionado (en sus variaciones flexibles, semirrígidos y rígidos), y primer (o quinto) radio hipermóvil.
Patent AU-2001247936-B2 (AU)
Title: Acoustic touchscreen having waveguided reflector arrays
Inventor: KAMBARA SHIGEKI
IPC: G06F3/033
Filed: 2001-04-04
Granted: 2005-07-21
Abstract: An acoustic touchscreen (1a) has transmitting transducers (23a, 23b) for generating acoustic signals which are deflected across a touch-sensitive area (2) by an array 13 of partially acoustically reflective elements 14. A touch on the touch-sensitive area causes a perturbation in the acoustic signals. After traversing the touch-sensitive area, the acoustic signals are redirected by another array 13 of partially acoustically reflective elements 14, towards receiving transducers (26a, 26b), where the signals (and any perturbations) are sensed. To accommodate touchscreens having narrow border regions (15a), the acoustic signals are propagated across the border regions using acoustic waveguides (18). The waveguide confines the acoustic signals to traveling along a narrow path width, but yet permit them to be deflected across the touch-sensitive area. In this manner, the transducers and reflective elements can in turn be of narrower construction and can fit within narrow border regions.
Patent AU-2001295190-B2 (AU)
Title: Process for the catalytic oxidation of hydrocarbons
Inventor: WOODFIN WILLIAM TERENCE
IPC: B01F23/10
Filed: 2001-04-30
Granted: 2005-12-22
Abstract: A process for the oxidation of a hydrocarbon, said process comprising partially oxidising in a reaction zone, a mixture comprising a hydrocarbon and an oxygen-containing gas in the presence of a catalyst which is capable of supporting oxidation of the hydrocarbon, wherein prior to said partial oxidation, said mixture comprising the hydrocarbon and the oxygen-containing gas is passed through a heat exchanger. Preferably the heat exchanger is a compact heat exchanger. Prior to passage through the heat exchanger a mixture of hydrocarbon and oxygen-containing gas may be passed through a baffle zone which comprises a housing containing at least one baffle plate. In a preferred embodiment, the invention relates to a process for the production of an olefin such as ethylene by the catalytic oxidative dehydrogenation of a hydrocarbon or mixture of hydrocarbons.
Patent AU-2002325051-B2 (AU)
Title: Configurations and methods of acid gas removal
Inventor: MAK JOHN
IPC: C10L3/10
Filed: 2002-09-17
Granted: 2007-03-15
Abstract: A plant includes an absorber ( 105 ) that receives a feed gas ( 10 ) at a pressure of at least 400 psig and comprising at least 5 mol % carbon dioxide, wherein the absorber ( 105 ) is operated at an isothermal or decreasing top-to-bottom thermal gradient, and wherein the absorber ( 105 ) employs a physical solvent to at least partially remove an acid gas from the feed gas ( 10 ). Such configuration advantageously provide cooling ( 108 ) by expansion of the rich solvent ( 21 ) generated in the absorber ( 105 ), wherein both a semi-rich solvent ( 13 ) generated and recycled to the absorber ( 105 ) and the feed gas ( 10 ) are cooled by expansion of the rich solvent ( 21 ).